{
    "__type__": "Deck", 
    "children": [], 
    "crowdanki_uuid": "2cedcbfa-bbde-11e7-a130-f40f241a83b0", 
    "deck_config_uuid": "fd4483b8-bbaf-11e7-86f5-f40f241a83b0", 
    "deck_configurations": [
        {
            "__type__": "DeckConfig", 
            "autoplay": true, 
            "crowdanki_uuid": "fd4483b8-bbaf-11e7-86f5-f40f241a83b0", 
            "dyn": false, 
            "lapse": {
                "delays": [
                    10
                ], 
                "leechAction": 0, 
                "leechFails": 8, 
                "minInt": 1, 
                "mult": 0.0
            }, 
            "maxTaken": 60, 
            "name": "Pharmacology", 
            "new": {
                "bury": false, 
                "delays": [
                    1, 
                    10
                ], 
                "initialFactor": 2500, 
                "ints": [
                    1, 
                    4, 
                    7
                ], 
                "order": 1, 
                "perDay": 200, 
                "separate": true
            }, 
            "replayq": true, 
            "rev": {
                "bury": false, 
                "ease4": 1.3, 
                "fuzz": 0.05, 
                "ivlFct": 1.0, 
                "maxIvl": 36500, 
                "minSpace": 1, 
                "perDay": 200
            }, 
            "timer": 0
        }
    ], 
    "desc": "", 
    "dyn": 0, 
    "extendNew": 10, 
    "extendRev": 50, 
    "media_files": [
        "paste-824633721001.jpg", 
        "paste-1679332212892.jpg", 
        "paste-1331439861913.jpg", 
        "med-9780198768814-graphic-010-full.jpg"
    ], 
    "mid": 1498440676344, 
    "name": "Pharmacology", 
    "note_models": [
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "cf6f413a-41bb-11e7-ba9b-f40f241a83b0", 
            "css": ".card {\n font-family: arial;\n font-size: 20px;\n text-align: center;\n color: black;\n background-color: white;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Front", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Back", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Card ID", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Source", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "ANZCA", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}<br>\n<br>\nSource: {{Source}}<br>\n\n", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Card 1", 
                    "ord": 0, 
                    "qfmt": "{{Front}}"
                }
            ], 
            "type": 0, 
            "vers": []
        }, 
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "css": ".card {\n font-family: arial;\n font-size: 20px;\n\n color: black;\n background-color: white;\n}\n", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Drug", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Class", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Uses", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Presentation", 
                    "ord": 3, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Action", 
                    "ord": 4, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Doses", 
                    "ord": 5, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Onset/Duration", 
                    "ord": 6, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Routes", 
                    "ord": 7, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Effects", 
                    "ord": 8, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Toxicity", 
                    "ord": 9, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Absorption", 
                    "ord": 10, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Distribution", 
                    "ord": 11, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Metabolism", 
                    "ord": 12, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Elimination", 
                    "ord": 13, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Number of uses", 
                    "ord": 14, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Number of routes", 
                    "ord": 15, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Systems affected", 
                    "ord": 16, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Source", 
                    "ord": 17, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Physical Properties", 
                    "ord": 18, 
                    "rtl": false, 
                    "size": 20, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "Pharmacology", 
            "req": [
                [
                    0, 
                    "any", 
                    [
                        0, 
                        14
                    ]
                ], 
                [
                    1, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    2, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    3, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    4, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    5, 
                    "any", 
                    [
                        0, 
                        15
                    ]
                ], 
                [
                    6, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    7, 
                    "any", 
                    [
                        0, 
                        15
                    ]
                ], 
                [
                    8, 
                    "any", 
                    [
                        0, 
                        16
                    ]
                ], 
                [
                    9, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    10, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    11, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    12, 
                    "all", 
                    [
                        0
                    ]
                ], 
                [
                    13, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [], 
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Uses}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Uses", 
                    "ord": 0, 
                    "qfmt": "What are the uses of {{Drug}}?<br>\n<br>List {{Number of uses}}\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Presentation}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Presentation", 
                    "ord": 1, 
                    "qfmt": "In what form/s is {{Drug}} presented?\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Physical Properties}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Physical Properties", 
                    "ord": 2, 
                    "qfmt": "What are the Physical Properties of {{Drug}}\n\n\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Action}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Action", 
                    "ord": 3, 
                    "qfmt": "What is the mechanism of action of {{Drug}}?\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Class}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Class", 
                    "ord": 4, 
                    "qfmt": "What class of drug is {{Drug}}\n<br>\nStructure?\n\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Doses}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Doses", 
                    "ord": 5, 
                    "qfmt": "In what doses can {{Drug}} be given? <br><br>\nThere are {{Number of routes}} doses to consider based on route.\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Onset/Duration}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Onset/Duration", 
                    "ord": 6, 
                    "qfmt": "What is the onset of {{Drug}}, and what is its duration?\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Routes}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Routes", 
                    "ord": 7, 
                    "qfmt": "In what routes can {{Drug}} be given? <br>\n<br>List {{Number of routes}}\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Effects}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Effects", 
                    "ord": 8, 
                    "qfmt": "What are the effects of {{Drug}}?<br><br>\nClassify by system<br>\n\nList {{Systems affected}}\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Toxicity}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Toxicity", 
                    "ord": 9, 
                    "qfmt": "What are the side effects/toxicity of {{Drug}}?<br>\n\n\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Absorption}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Absorption", 
                    "ord": 10, 
                    "qfmt": "How is {{Drug}} absorbed?\nWhat is its bioavailability?\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Distribution}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Distribution", 
                    "ord": 11, 
                    "qfmt": "What is the distribution of {{Drug}}?\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Metabolism}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Metabolism", 
                    "ord": 12, 
                    "qfmt": "How is {{Drug}} metabolised?\n\n\n"
                }, 
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Elimination}}\n<br>\n{{Source}}", 
                    "bafmt": "", 
                    "bqfmt": "", 
                    "did": null, 
                    "name": "Elimination", 
                    "ord": 13, 
                    "qfmt": "How is {{Drug}} excreted?\n\n\n"
                }
            ], 
            "type": 0, 
            "vers": []
        }
    ], 
    "notes": [
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Fentanyl", 
                "Synthetic phenylpiperidine<div><img src=\"paste-1679332212892.jpg\" /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia component of GA</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Combination with tranquilizer to produce neuroleptanalgesia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia during labour when regional anaesthesia is not in use</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Premedication</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Palliative care</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clear, colourless solution: 50 microg/mL of fentanyl citrate</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Transdermal patches: 12/25/50/75/100 microg/hour over 72 hr</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Sublingual tabs 100/200/400/600/800 microg</div><div><br /></div>", 
                "<div>Highly selective mu-agonist (MOP)</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Premedication IM: 50-100 microg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Induction: IV 1-100 microg/kg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Epidural: 50-100 microg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Spinal: 5- 25 microg</div><div><br /></div>", 
                "<div>&nbsp;•\tOnset&nbsp;</div><div>&nbsp;◦\t2-5 minutes&nbsp;</div><div><br /></div><div>&nbsp;•\tDuration of Action&nbsp;</div><div>&nbsp;◦\t30-60 min (small dose)</div><div>&nbsp;◦\t4-6 hours (high dose &gt; 50 microg/kg)&nbsp;</div><div>&nbsp;◦\tPatches: equilibrium conc 12-24 hours\n</div><div><br /></div>", 
                "PO, IM, Subcut, IV, Epidural, Intrathecal", 
                "<div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>CNS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia (50-80 times more potent than morphine)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Little hypnotic/sedative activity</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Miosis (stimulates EW nucleus)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Nausea and Vomiting may occur</div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>CVS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Bradycardia (vagal) - most significant</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>No effect on CO, MAP, PVR/SVR, pulmonary capillary wedge pressure</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Obtunds cardiovascular response to laryngoscopy/intubation</div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Resp</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Portent respiratory depressant: decreases RR and TV</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduces ventilatory response to hypoxia/hypercarbia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Anti-tussive</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Chest wall rigidity (\"wooden chest phenomenon\"</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Minimal histamine release (rarely bronchospasm)</div><div><br /></div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Endocrine</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>▪<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>High doses obtund the metabolic stress response to surgery</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>▪<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>No effect on WBC function</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>▪<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Does not increase activity of ADH (unlike morphine)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span><b>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>GI</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Decreases GI motility</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Decreases gastric acid secretion</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Doubles CBD pressure by causing sphincter of Oddi spasm</div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Other</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Increases tone of ureters/bladder detrusor muscle and vesicular sphincter</div><div><br /></div>", 
                "Respiratory depression may occur post-operatively, possibly related to the appearance of a secondary peak in the plasma fentanyl concentration due to elution from muscle. Nausea, vomiting, and dependence may also complicate the use of the drug.", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Bioavailability of 33 %</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Becomes highly ionised in the stomach (99.9 %) --&gt; slow absorption&nbsp;</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Transdermal - 47 % absorption at 24 hours; 88 % &nbsp;at 48 hours, 94 % at 72 hours</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Protein Binding - ~90 %</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Vd 0.88-4.41 L/kg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Short duration of action d/t redistribution</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Continuous administration --&gt; tissue saturation and prolonged duration&nbsp;</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Lipid soluble (more so than morphine) - crosses BBB more easily</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>▪<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Much more rapid onset of action than morpine</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Intrathecal admin doesn’t cause delayed resp depression (unlike morphine) because it is rapidly absorbed into the spinal cord</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Primarily by N-dealkylation to norfentanyl&nbsp;</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Fentanyl + Norfentanyl undergo hydroxylation to hydoxypropionyl derivatives</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Also hydroxylation and amide hydrolysis</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Mainly by Cytochrome P450 3A4 (in liver and intestine)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Non-active metabolites</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>10 % of fentanyl excreted in urine</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clearance 13 ml/kg/min</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Elimination half life 141-853 min</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduced clearance in renal and hepatic impairment</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>PO ritonavir = potent inhibitor of CYP3A4, prolongs clearance by 2/3</div><div><br /></div>", 
                "5", 
                "5", 
                "6", 
                "Drugs in Anasesthesia and Intensive Care (Oxford)", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>pKa 8.4</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>9 % ionized at pH 7.4</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Highly lipid soluble (octanol:water coefficient 717)</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "Cm>w`jhXM2", 
            "note_model_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "tags": [
                "opioids", 
                "pharmacology,"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Dexamethasone", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                "", 
                ""
            ], 
            "flags": 0, 
            "guid": "ee;+p=Mtt7", 
            "note_model_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Suxamethonium", 
                "Depolarising neuromuscular blocking agent<div><img src=\"med-9780198768814-graphic-010-full.jpg\" /></div><div>The dicholine ester of succinic acid (equivalent to two acetylcholine molecules joined back-to-back).</div>", 
                "<div>Suxamethonium is used:</div><div><br /></div><div>&nbsp; &nbsp; 1. wherever rapid and profound neuromuscular blockade is required, e.g. to facilitate tracheal intubation and</div><div><br /></div><div>&nbsp; &nbsp; 2. for the modification of fits after electroconvulsive therapy.</div>", 
                "As a clear aqueous solution containing 50 mg/ml of suxamethonium chloride; the preparation should be stored at 4°C", 
                "Neuromuscular blockade of brief duration in skeletal muscle.&nbsp;<div><br /></div><div>Acts on the nicotinic Ach receptor in the post-synaptic membrane of the neuromuscular junction. Causes prolonged depolarization of skeletal muscle fibres to a membrane potential above which an action potential can be triggered.</div><div><div><br /></div></div>", 
                "The intravenous dose is 0.5– 2.0 mg/kg; the onset of action occurs within 30 seconds, and the duration of action is 3–5 minutes. Infusion of a 0.1% solution at 2–15 mg/kg/hour will yield 90% twitch depression. The intramuscular dose is up to 2.5 mg/kg. Equal doses on a mg/kg basis have a shorter duration of action in infants. The drug may also be administered sublingually at a dose of 2 mg/kg<div><br /></div><div>Total body weight should be used to calculate drug dosage in morbidly obese individuals.</div>", 
                "The intravenous dose is 0.5– 2.0 mg/kg;<b><font color=\"#2b2cff\"> the onset of action occurs within 30 seconds, and the duration of action is 3–5 minutes.</font></b>&nbsp;<div><br /></div><div><b><font color=\"#2b2cff\">Equal doses on a mg/kg basis have a shorter duration of action in infants.</font></b>&nbsp;<div><br /></div></div>", 
                "IV, IM, SL, infusion", 
                "<div>CVS</div><div>With repeated doses of suxamethonium, bradycardia and a slight increase in mean arterial pressure may occur.</div><div><br /></div><div>RS</div><div>Apnoea occurs subsequent to skeletal muscle paralysis.</div><div><br /></div><div>CNS</div><div>The administration of suxamethonium may initially cause fasciculations which are then followed by a phase I depolarizing block. The characteristics of this during partial paralysis are:</div><div><br /></div><div>&nbsp; &nbsp; 1. well-sustained tetanus during stimulation at 50–100 Hz</div><div><br /></div><div>&nbsp; &nbsp; 2. the absence of post-tetanic facilitation</div><div><br /></div><div>&nbsp; &nbsp; 3. train-of-four ratio &gt;0.7 and</div><div><br /></div><div>&nbsp; &nbsp; 4. potentiation by anticholinesterases.</div><div><br /></div><div>With repeated administration or a large total dose, a phase II block may develop. The characteristics of this during partial paralysis are:</div><div><br /></div><div>&nbsp; &nbsp; 1. poorly sustained tetanus</div><div><br /></div><div>&nbsp; &nbsp; 2. post-tetanic facilitation</div><div><br /></div><div>&nbsp; &nbsp; 3. train-of-four ratio &lt;0.3</div><div><br /></div><div>&nbsp; &nbsp; 4. reversal by anticholinesterases and</div><div><br /></div><div>&nbsp; &nbsp; 5. tachyphylaxis.</div><div><br /></div><div>Intracranial and intraocular pressures are both raised, following the administration of suxamethonium.</div><div><br /></div><div>AS</div><div>The intragastric pressure increases by 7–12 cmH2O; the lower oesophageal sphincter tone simultaneously decreases with the use of suxamethonium. Salivation and gastric secretions are increased.</div><div><br /></div><div>Metabolic/other</div><div>Serum potassium concentration is briefly increased in normal individuals by 0.2–0.4 mmol/l.</div>", 
                "<div>Eight side effects (dr podcast)</div><div><br /></div><div>1) Myalgia&nbsp;- common, especially in women, the middle-aged, and those ambulant early in the post-operative period.&nbsp;</div><div>2) Disrhythmias - most commonly bradycardia, usually sinus or nodal but could be ventricular. Most commonly in paeds and with&nbsp;repeated dosing.</div><div>3) HyperK - In most individuals a transient rise of 0.5mmol/L occurs which rapidly resolves. Hyperkalaemic response is markedly exaggerated in patients with burns or major denervation of muscle and acute or chronic renal failure; this may lead to cardiac arrest.&nbsp;</div><div><br /></div><div>4) &nbsp;Intraocular pressure is transiently raised (10-15mmHg) following the use of suxamethonium—the drug should be used with caution in patients with penetrating eye injuries. Thiopentone can offset</div><div><br /></div><div>5) Raised intragastric pressure - increases by 7–12 cmH2O; the lower oesophageal sphincter tone simultaneously decreases with the use of suxamethonium.</div><div><br /></div><div>6) There have been many reports of fatal anaphylactoid reactions with the administration of suxamethonium.</div><div><br /></div><div>7)&nbsp;Suxamethonium apnoea</div><div><br /></div><div>8) MH -&nbsp;Suxamethonium is a potent trigger agent for the development of malignant hyperthermia and may cause generalized contractures in those patients exhibiting myotonia. &nbsp;</div><div><br /></div><div>Cross-sensitivity exists with many of the non-depolarizing drugs, following administration of suxamethonium.</div>", 
                "Absorbed poorly and to varying extent from GI tract (as are other quarternary ammoniums)", 
                "An initial rapid redistribution phase may contribute to the brief duration of action of the drug. Suxamethonium appears to be protein-bound to an unknown extent.", 
                "The drug is hydrolysed by plasma cholinesterase (EC 3.1.1.8) to succinylomonocholine (which is weakly active) and choline; the former is further hydrolysed by plasma cholinesterase to succinic acid and choline. Eighty percent of an administered dose is hydrolysed before it reaches the neuromuscular junction.", 
                "2–10% of an administered dose is excreted unchanged in the urine. The in vivo hydrolysis rate is 3–7 mg/l/min, and the half-life 2.7– 4.6 minutes.", 
                "2", 
                "4", 
                "5", 
                "Oxford drugs + Dr Podcast<div>https://pubchem.ncbi.nlm.nih.gov/compound/succinylcholine#section=Top</div>", 
                "The dicholine ester of succinic acid (equivalent to two acetylcholine molecules joined back-to-back).<div><br /></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>290.404 g/mol</div><div><br /></div><div>Suxamethonium is pharmaceutically incompatible with thiopental.</div><div>Incompatible with alkaline compounds, must be kept refrigerated</div>"
            ], 
            "flags": 0, 
            "guid": "m_wkCd~K4y", 
            "note_model_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "tags": [
                "NMBA"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What dose of fentanyl is used for intubation in paediatric cases?", 
                "2 micrograms/kg", 
                "", 
                ""
            ], 
            "flags": 0, 
            "guid": "mq`X=(M#G7", 
            "note_model_uuid": "cf6f413a-41bb-11e7-ba9b-f40f241a83b0", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Remifentanyl", 
                "Synthetic derivative of fentanyl (phenylpiperidine)<div><br /></div><div><img src=\"paste-824633721001.jpg\" /></div><div><br /></div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesic component to general anaesthesia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>ICU analgesia/anaesthesia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia in labour when regional anaesthesia not in use</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia/sedation during awake fibreoptic intubation</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>White lyophilized powder to be reconstituted - remifentanyl hydrochloride in glycine buffer</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>1/2/5 mg vials</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia and respiratory depression</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Pure mu-agonist (MOP)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduces amount of volatile/hypnotic agent</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Slow IV bolus of <b>1 microg/kg</b> over at least 30 sec</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>TCI -&nbsp;<b>0.0125-1 microg/kg/min</b></div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Peak effect 1-3 minutes</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Rapid offset and predictable even after prolonged infusion (5-10 min)</div><div><br /></div>", 
                "IV", 
                "<div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>CNS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Centrally mediated vagal activity</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Similar analgesic potency to fentanyl</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Minimal sedative/hypnotic activity</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Miosis (EW stimulation)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Low incidence of N&amp;V</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Short duration of action = more pronounced post-op discomfort if used as sole agent</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span><b>CVS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Decreases MAP and HR by 20 %</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>May decrease myocardial contractility and CO</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Bradycardia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span><b>Resp</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Potent respiratory depressant (decrease RR and TV)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Diminishes ventilatory response to hypoxia and hypercarbia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Chest wall rigidity (? Mu-receptors on GABA-ergic interneurons)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>NO HISTAMINE RELEASE</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span><b>GI</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Decreases motility</div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Other</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Hepatic impairment = more sensitive to resp depressant effects</div><div><br /></div>", 
                "<div>Respiratory depression, bradycardia, nausea, and vomiting may all complicate the use of remifentanil. Because of its short duration of action, post-operative discomfort may be pronounced if remifentanil is used as a sole analgesic agent perioperatively.</div><div><br /></div>", 
                "100 % - IV only", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Protein binding 70 % (2/3 to alpha 1 acid glycoprotein)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Low Lipid solubility&nbsp;</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Low Vd of 0.1 L/kg (SS to peripheral tissues 0.25-0.4 L/kg)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Crosses placenta</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Neonatal Vd = 2 x adult</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Context sensitive half life 3-5 minutes</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Rapid ester hydrolysis by non-specific plasma and tissue esterases to carboxylic acid derivative = remifentanyl acid</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>•<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>4600-fold less potent</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Short CSt1/2 because of large amount of esterases</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Not metabolised by plasma cholinesterases</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clearance 4.2-5 L/min independent of renal and hepatic function</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>95 % excreted in urine as the acid (1.5-2 hours half life)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Renal impairment can cause build up of the acid metabolite but is not clinically significant</div><div><br /></div>", 
                "4", 
                "1", 
                "5", 
                "Oxford Drugs", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>pKa 7.1</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>68 % unionized at pH 7.4</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "L{&}mg/g*3", 
            "note_model_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "tags": []
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Alfentanil", 
                "Synthetic phenylpiperidine derivative<div><br /></div><div><img src=\"paste-1331439861913.jpg\" /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesic component to GA</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Sedation for ICU</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Obtund cardiovascular response to laryngoscopy</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clear colourless solution for injection</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>0.5 or 5 mg/mL of alfentanil hydrochloride&nbsp;</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Analgesia and respiratory depression</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Highly selective mu-agonist (MOP)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduces amount of volatile/hynotic agent needed for anaesthesia maintenance</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>IV 5-50 microg/kg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Infusion 0.5-1 microg/kg/min</div><div><br /></div>", 
                "Onset - peak effect within <b><font color=\"#1a00f5\">90 sec</font></b><div><br /></div><div>Duration - <b><font color=\"#1a00f5\">5-10 min</font></b> (shorter than fentanyl d/t smaller Vd and shorter elimination half life)</div>", 
                "IV", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span><b>CNS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>10-20 times more potent than morphine</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Little hypnotic/sedative activity</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Miosis (EW stimulation)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduces intra-ocular pressure by 45 %</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Increase amplitude of EEG + reduces frequency</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>N&amp;V</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span></div><div><b>CVS</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Bradycardia is the most significant effect (vagal)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>No effect on CO, MAP, PVR/SVR, PCWP</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Obtunds cardiovascular response to laryngoscopy and intubation</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Resp</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Potent respiratory depressant (reduces TV and RR)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Diminishes response to hypoxia and hypercarbia</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Antitussive</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Chest wall rigidity</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Minimal histamine release (thus rarely bronchospasm)</div><div>&nbsp;</div><div><b><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Renal</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Increases tone in ureters, bladder detrusor and vesicular sphincter</div><div><br /></div><div><b>Endocrine</b></div><div></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Obtunds metabolic stress response to surgery (more effective than fentanyl)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Does not increase ADH (unlike morphine)</div><div><b><br /></b></div><div><b>GI</b></div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Slows motility</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Reduces gastric acid secretion</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Doubles CBD pressure</div><div><br /></div>", 
                "<div>Respiratory depression, bradycardia, nausea, vomiting, and dependence may also complicate the use of the drug</div><div><br /></div>", 
                "<div>100 % - IV</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Protein binding 85-92 % (alpha 1 acid glycoprotein)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Vd 0.4-1 L/kg</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Crosses the placenta</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Mainly in Liver by N-dealkylation to noralfentanil</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Remainder by: aromatic hydroxylation, demethylation, amide hydrolysis followed by acetylation</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Major phase II is via conjugation to glucuronide</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>CYP450 3A4 is a major player in metabolism - subject to competitive inhibition by midazolam</div><div><br /></div>", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>90 % excreted in urine (&lt; 1 % as unchanged drug)</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clearance 3.3-8.3 mL/kg/min</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Half life 90-111 min</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Clearance inhibited by co-admin of erythromycin, cimetidine, fluconazole, ketoconazole, ritonavir, diltiazem</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Half life prolonged in elderly and in significant hepatic/renal impairment&nbsp;</div><div><br /></div>", 
                "3", 
                "1", 
                "6", 
                "Oxford Drugs", 
                "<div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>pKa 6.5</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>89 % unionized at ph 7.4</div><div><span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>◦<span class=\"Apple-tab-span\" style=\"white-space:pre\"> </span>Low lipid solubility (octanol:water partition 128.1)</div><div><br /></div>"
            ], 
            "flags": 0, 
            "guid": "x:6K|IRm71", 
            "note_model_uuid": "a734c0b3-503b-11e7-9937-0025bcdd42f8", 
            "tags": []
        }
    ]
}